Goldberg Andrew D. 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Jun 21, 2023
Insider Transaction Report
Form 4
Goldberg Andrew D.
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-06-16−2,000→ 0 total→ Common Stock (2,000 underlying) - Exercise/Conversion
Common Stock
2023-06-16+2,000→ 2,000 total
Footnotes (3)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F2]Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F3]RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.